🕵️ Soleno Therapeutics Inc ($SLNO)
SEC insider & ownership activity, last 12 months · CIK 1484565 · every row links its SEC filing
Over the last 12 months insiders sold $429K with no open-market buying against it. Manning Meredith sold $229K in discretionary trades (Mar). Blackrock, Inc. added 5.5% → 6.9%. One red-flag 8-K in the window: Delisting notice (3.01), May 18, 2026.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 2 sellers, $429K (6 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Manning Meredith | 0 | – | 3 | $229K | Mar 27, 2026 |
| Michael F. Huang | 0 | – | 3 | $200K | Mar 27, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Wellington Management Group LLP | 8.6% | 13G | May 15, 2026 | filing ↗ | |
| Wellington Group Holdings LLP | 8.6% | 13G | May 15, 2026 | filing ↗ | |
| Wellington Investment Advisors Holdings LLP | 8.6% | 13G | May 15, 2026 | filing ↗ | |
| Wellington Management Company LLP | 8.3% | 13G | May 15, 2026 | filing ↗ | |
| Blackrock, Inc. | 6.9% | 13G | Apr 24, 2026 | filing ↗ | |
| State Street Corporation | 5.2% | 13G | May 12, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Abingworth Bioventures VII LP | $110.7M | Aug 11, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Agreement terminated (1.02) | May 18, 2026 | filing ↗ |
| Acquisition or disposition (2.01) | May 18, 2026 | filing ↗ |
| Delisting notice (3.01) | May 18, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | May 18, 2026 | filing ↗ |
| Change of control (5.01) | May 18, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 18, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | May 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 18, 2026 | filing ↗ |
| Other events (8.01) | Apr 7, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 5, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 5, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Mar 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 16, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 25, 2026 | filing ↗ |
| Other events (8.01) | Feb 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 25, 2026 | filing ↗ |
| Earnings (2.02) | Feb 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 25, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 21, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 21, 2026 | filing ↗ |
| Earnings (2.02) | Jan 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 12, 2026 | filing ↗ |
| Material agreement (1.01) | Nov 10, 2025 | filing ↗ |
| New financial obligation (2.03) | Nov 10, 2025 | filing ↗ |
| Other events (8.01) | Nov 10, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 10, 2025 | filing ↗ |
| Earnings (2.02) | Nov 4, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 4, 2025 | filing ↗ |
| Officer/director changes (5.02) | Oct 13, 2025 | filing ↗ |